DiabetesIndia 2022: Update on Diabetes Prevention |
Conferences
eMediNexus Coverage from: 
DiabetesIndia 2022: Update on Diabetes Prevention
Dr Anil Kumar Virmani, Jamshedpur,  07 June 2022
Coronavirus Live Count Map India

remove_red_eye 710 Views
COVID-19 Vaccine Updates


#Diabetes and Endocrinology #Multispeciality

0 Read Comments                

  • Awareness and education of all (right from schools) are very important.
  • Strategies to screen for prediabetes and assessment of individual risk factors are the need of the hour.
  • Prediabetes needs to be further classified for risk stratification - Not all patients behave similarly.
  • All patients with prediabetes should be counseled for intensive lifestyle modification.
  • Clustering of prediabetes is a novel and emerging concept.
  • Recognizing the heterogeneity of treatment effects, metformin therapy should also be limited to individuals who are at the highest risk and most likely to benefit, including those who are younger, more obese, more hyperglycemic or who have histories of GDM and cluster 3 and 5.
  • Looking beyond guidelines - Pioglitazone and SGLT2 inhibitors, appear to be of immense benefit in clusters 3, 5 and 6.
To comment on this article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now